F Star Therapeutics Is A Clinical Stage Biopharmaceutical Company Dedicated To Developing Innovative Multispecific Antibody Therapeutics Aimed At Treating Cancer And Other Serious Illnessesthe Company Specializes In Tetravalent Bispecific Antibodies That Target Multiple Antigens Simultaneouslyenhancing Therapeutic Efficacy And Improving Patient Outcomesits Pipeline Includes Key Candidates Such As Fs118Fs120Fs222And Sb 11285Which Focus On Addressing Treatment Failures And Improving Outcomes In Various Clinical Settings Headquartered In Cambridgeenglandf Star Therapeutics Operates Primarily In The Uk And The Usthe Company Has Established Partnerships With Major Pharmaceutical Firmsincluding Denali Therapeutics Inc Merck Kgaaand Takeda Pharmaceutical Company Limitedto Advance Its Research And Development Efforts Across Multiple Therapeutic Areasf Star Therapeutics Continues To Focus On Its Bispecific Antibody Platform To Discover Next Generation Therapeutics
No conferences found for this company.
| Company Name | F Star Beta Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
